Comparison of diclofenac spray and gel on knee joints of patients with osteoarthritic pain

Clinical Drug Investigation

Volumn 18, Issue 5, 1999, Pages 345-354

  Kilminster, Shaun C ^a   Mould, Graham P ^a  

^a ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; UNCLASSIFIED DRUG; VOLTAREL EMULGEL;

ADULT; AEROSOL; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; GASTROINTESTINAL SYMPTOM; GEL; HUMAN; KNEE OSTEOARTHRITIS; MALE; PAIN ASSESSMENT; PHARMACOKINETICS; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION;

EID: 0032741951     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199918050-00002     Document Type: Article

References (19)

1. Roth A. A controlled clinical investigation of 3% diclofenac 2.5% sodium hyaluronate topical gel in the treatment of uncontrolled pain in chronic oral NSAID users with osteoarthritis. Int J Tissue React 1995; 17 (4): 129-32
2. Burner A. A new topical form of diclofenac (Voltaren Emulgel). A review of clinical trials. Clin Exp Rheumatol 1987; 1 (5) Suppl. 2: 224
3. Reiss W, Scmid K, Botta L, et al. Die perkuntane resorption von diclofenac. Arzneunittelforschung Drug Res 1986; 36 (II): 1092-6
4. Radermather J, Jentsch D, Scholl MA. et al. Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. Br J Clin Pharmacol 1991; 31: 537-41
5. Singh P, Roberts MS. Skin permeability and local tissue concentrations of nonsteroidal anti-inflammatory drugs after topical application. J Pharmacol Exp Ther 1994; 268: 144-51
6. Davies NM, Anderson KE. Clinical pharmacokinetics of diclofenac. Clin Pharmacokinet 1997; 33 (3): 184-213
7. Kilminster SG. Manual for the short pain inventory. Selsey (Sussex): Lawrencian Clinical Publications, 1988
8. Pocock SJ. Clinical trials: a practical approach. Chichester: John Wiley and Sons, 1985
9. Statistica. Statistical Manual I. Tulsa (OK): Statsoft, 1994
10. Kerlinger FN. Foundations of behavioural research. New York: Holt, Rinehart & Winston, 1973
11. Hayes WL. Statistics. New York: Holt, Rinehart & Winston, 1988
12. Torrejon VA. Treatment of severe rheumatic pain with aceclofenac versus placebo. Acta Ther 1988; 14: 275-80
13. Russell A. A double blind comparison of the efficacy and safety of topical 3% diclofenac in 2.5% sodium hyaluronate acid gel with placebo for the treatment of ostcoarthritis or chronic capsulitis. Presented at the International Society for Rheumatic Therapy. 4th Biannual Congress; 1994 May 6; Chantilly, VA, USA: 1994
14. Spielberger CD. In: Gorsuch R, Lushene RE, editors. The STAI manual. California, USA: Consulting Psychologists Press, 1974
15. Torri G, Vignati C, Agrifoglio E, et al. Aceclofenac versus piroxicam in the management of osteoarthritis of the knee: a double blind controlled study. Curr Ther Res Clin Exp 1994; 55: 576-83
16. Ward DE, Veys EM, Bowdler JM, et al. Comparison of aceclofenac with diclofenac in the treatment of osteoarthritis. Clin Rheumatol 1995; 14: 656-62
17. Diaz C, Rodriguez de la Serna A, Geli C, et al. Efficacy and tolerability of aceclofenac versus diclofenac in the treatment of knee osteoarthritis: a multicentre study. Eur J Rheumatol Inflamm 1996; 16: 17-22
18. Lequesne M, Mery C, Sampson M, et al. Indexes of severity for osteoarthritis of the hip and knee. Validation value in comparing with other assessment tests. Scand J Rheumatol 1987; 16 Suppl. 65: 85-9
19. Oppenheim AN. Questionnaire design and attitude measurement. Portsmouth (NH): Heinmann, 1968